Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: June 29, 2011...Who Wins When Apple Ditches Samsung?

Responding to LL....

I never suggested that there was "some ongoing agreement that the value of the other portfolios in commingled license deals would be "reduced to an amount approaching zero"."

The discussion was about the Apple license and associated commingling, and that license only.

The commingling handling approach for the future (since 10/6/11) is as addressed in the settlement agreement - were PTSC will presumably have a say in the appropriate allocation of revenues.

I hope this clarifies....

SGE

Share
New Message
Please login to post a reply